Calamos Advisors
HLGN

Calamos Advisors’s Heliogen, Inc. HLGN Stock Holding History

Calamos Advisors’s Portfolio HLGN Stock Details HLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,429
Closed -$3.97M – 1185
2021
Q3 		$3.97M Buy
+11,429
New +$3.96M 0.02% 671

Other funds holding HLGN

PML
Prime Movers Lab Jackson, Wyoming $13.5M AUM 0% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCA
Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
NC
NZS Capital Denver, Colorado $3B AUM 21.29% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Calamos Advisors's HLGN Position: Q4 2021 in Review

Calamos Advisors sold out of Heliogen, Inc. (HLGN) in Q4 2021, closing a stake of 11,429 shares — an estimated $3.97M sold.

Calamos Advisors first reported a position in HLGN in Q3 2021 and held it in 1 quarter. The position peaked at $3.97M in Q3 2021. 25 funds tracked by Wall St. Rank hold HLGN as of Q4 2021.

  • Calamos Advisors reported no remaining Heliogen, Inc. position as of Q4 2021 after selling out during the quarter.
  • Calamos Advisors sold 11,429 Heliogen, Inc. shares in Q4 2021, an estimated $3.97M.
  • Calamos Advisors first reported a position in Heliogen, Inc. in Q3 2021 and held it in 1 quarter.
  • Calamos Advisors's Heliogen, Inc. position peaked at $3.97M in Q3 2021.
  • 25 funds tracked by Wall St. Rank held Heliogen, Inc. as of Q4 2021.

Based on Calamos Advisors's 13F filing for Q4 2021, filed 1 Feb 2022.